
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of sponsors will be available once they are confirmed.
Register now for the 17th Welsh Conference of the Primary Care Diabetes & Obesity Society. Through our expert-led series of lectures, masterclasses and case studies, you will learn about the latest evidence and guidelines to help you optimise your care of diabetes, metabolic disease and obesity. With major changes to NICE guidance and service pathways in Wales this year, you will not want to miss out on this free learning opportunity delivered by primary care, for primary care.
Masterclasses offering hands-on tips that will influence your everyday clinical practice
Inspiration and new contacts with various opportunities to network alongside your peers
Claim 5 CPD points for this one-day conference, and receive a workbook to build your CPD profile, supplemented by associated online materials
17th Welsh Conference of the Primary Care Diabetes & Obesity Society 2026
Date: Thursday 7 May 2026
Location: Leonardo Hotel, Cardiff

Heather Bell
GP Principal, Carrickfergus

Pam Brown
GP, Swansea

Sarah Davies
GP Partner, Woodlands Medical Centre, Cardiff

Su Down
Diabetes Nurse Consultant, Somerset

Vanessa Goulding
Acting Head of Podiatry and National Strategic Lead for Diabetes Foot Care

David Millar-Jones
GP, Cwmbran

Julie Lewis
Primary Care Nurse Consultant / Clinical Lead for Diabetes, North Wales

Nicola Milne
Primary Care Diabetes Specialist Nurse Diabetes Specialist Nurse Clinical lead for the Greater Manchester Diabetes Strategic Clinical Network

Roy Taylor
Emeritus Professor of Medicine and Metabolism, University of Newcastle

Tom Pembroke
Consultant Hepatologist and Senior Clinical Researcher, University Hospital of Wales, Cardiff

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.
At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor glucose and providing healthcare professionals with more data to make better informed treatment decisions.

Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.




This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of sponsors will be available once they are confirmed.